# Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

> **NCT01203358** · PHASE2,PHASE3 · COMPLETED · sponsor: **NICHD Neonatal Research Network** · enrollment: 617 (actual)

## Conditions studied

- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Exosurf
- **DRUG:** Survanta

## Key facts

- **NCT ID:** NCT01203358
- **Lead sponsor:** NICHD Neonatal Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-01
- **Primary completion:** 1992-01
- **Final completion:** 1992-01
- **Target enrollment:** 617 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203358, "Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01203358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*